Poseida Therapeutics, Inc.
PSTX
Transaktioner
328
Köp
180
Sälj
148
Nettoinsynsflöde
15.7 mn USD
Köpvärde minus säljvärde
Rapportanalys
Senast rapporterade siffror, automatiskt granskadeLäser senaste rapporten…
Aktiekurs och insynstransaktioner
Ingen prisdata ännuIngen prisserie har matchats mot detta bolag ännu.
Avkastning efter transaktion
Median-% efter transaktionsdatumKursserien för detta bolag rör sig i tick som är stora i förhållande till aktiekursen, så procentuell avkastning skulle domineras av avrundningsbrus snarare än av verkliga kursrörelser. Avkastningsstatistik visas därför inte.
Signalkorrelation
Månatligt nettoinsynsflöde vs avkastning–
Pearsonkorrelation mellan den signerade logaritmen av månatligt nettoinsynsköp och den månadens aktiekursavkastning, över 0 månader med aktivitet. Värden nära noll innebär att insynsflödet inte gav någon timinginformation för detta bolag.
Alla rapporterade transaktioner
328 rader| Datum | Person | Position | Typ | Volym | Pris | Värde |
|---|---|---|---|---|---|---|
| 2025-01-08 | Malin Life Sciences Holdings Ltd | 10% owner | Sell | 11.8 mn | – | – |
| 2025-01-08 | Malin Life Sciences Holdings Ltd | 10% owner | Sell | 11.8 mn | – | – |
| 2025-01-08 | Amado Rafael | Director | Sell | 59 k | – | – |
| 2025-01-08 | BAUM CHARLES M | Director | Sell | 79 k | – | – |
| 2025-01-08 | Collins Cynthia | Director | Sell | 59 k | – | – |
| 2025-01-08 | Corning Luke | Director | Sell | 59 k | – | – |
| 2025-01-08 | Gergen Mark J | President and CEO | Sell | 637 k | – | – |
| 2025-01-08 | LEONHARDT HARRY J | GC & Chief Compliance Officer | Sell | 224 k | – | – |
| 2025-01-08 | Lloyd Marcea Bland | Director | Sell | 69 k | – | – |
| 2025-01-08 | Mylet Johanna | Chief Financial Officer | Sell | 255 k | – | – |
| 2025-01-08 | Yarema Kristin | President and CEO | Sell | 616 k | – | – |
| 2025-01-08 | Gergen Mark J | President and CEO | Sell | 637 k | – | – |
| 2025-01-08 | LEONHARDT HARRY J | GC & Chief Compliance Officer | Sell | 224 k | – | – |
| 2025-01-08 | Rizvi Syed Ali-aamir | Chief Medical Officer | Sell | 185 k | – | – |
| 2025-01-08 | Mylet Johanna | Chief Financial Officer | Sell | 255 k | – | – |
| 2025-01-08 | BAUM CHARLES M | Director | Sell | 79 k | – | – |
| 2025-01-08 | Collins Cynthia | Director | Sell | 59 k | – | – |
| 2025-01-08 | Lloyd Marcea Bland | Director | Sell | 69 k | – | – |
| 2025-01-08 | Schmid John P. | Director | Sell | 59 k | – | – |
| 2025-01-08 | Corning Luke | Director | Sell | 59 k | – | – |
| 2025-01-08 | Amado Rafael | Director | Sell | 59 k | – | – |
| 2025-01-08 | Rizvi Syed Ali-aamir | Chief Medical Officer | Sell | 185 k | – | – |
| 2025-01-08 | Schmid John P. | Director | Sell | 59 k | – | – |
| 2025-01-08 | Yarema Kristin | President and CEO | Sell | 616 k | – | – |
| 2025-01-02 | Gergen Mark J | Executive Chairman | Sell | 23 k | 9,60 | 224 k USD |
| 2025-01-02 | Gergen Mark J | Executive Chairman | Sell | 23 k | 9,60 | 224 k USD |
| 2024-12-10 | Gergen Mark J | Executive Chairman | Buy | 30 k | 2,78 | 83 k USD |
| 2024-12-10 | Gergen Mark J | Executive Chairman | Sell | 30 k | 9,46 | 284 k USD |
| 2024-12-10 | Gergen Mark J | Executive Chairman | Buy | 30 k | 2,78 | 83 k USD |
| 2024-12-10 | Gergen Mark J | Executive Chairman | Sell | 30 k | 9,46 | 284 k USD |
| 2024-11-26 | Gergen Mark J | Executive Chairman | Buy | 30 k | 2,78 | 83 k USD |
| 2024-11-26 | Gergen Mark J | Executive Chairman | Sell | 30 k | 9,27 | 278 k USD |
| 2024-11-26 | Gergen Mark J | Executive Chairman | Buy | 30 k | 2,78 | 83 k USD |
| 2024-11-26 | Gergen Mark J | Executive Chairman | Sell | 30 k | 9,27 | 278 k USD |
| 2024-06-17 | Amado Rafael | Director | Buy | 20 k | 0,00 | 0 USD |
| 2024-06-17 | BAUM CHARLES M | Director | Buy | 20 k | 0,00 | 0 USD |
| 2024-06-17 | Collins Cynthia | Director | Buy | 20 k | 0,00 | 0 USD |
| 2024-06-17 | Corning Luke | Director | Buy | 20 k | 0,00 | 0 USD |
| 2024-06-17 | Lloyd Marcea Bland | Director | Buy | 20 k | 0,00 | 0 USD |
| 2024-06-17 | Amado Rafael | Director | Buy | 20 k | 0,00 | 0 USD |
| 2024-06-17 | BAUM CHARLES M | Director | Buy | 20 k | 0,00 | 0 USD |
| 2024-06-17 | Collins Cynthia | Director | Buy | 20 k | 0,00 | 0 USD |
| 2024-06-17 | Corning Luke | Director | Buy | 20 k | 0,00 | 0 USD |
| 2024-06-17 | Lloyd Marcea Bland | Director | Buy | 20 k | 0,00 | 0 USD |
| 2024-06-17 | Schmid John P. | Director | Buy | 20 k | 0,00 | 0 USD |
| 2024-06-17 | Schmid John P. | Director | Buy | 20 k | 0,00 | 0 USD |
| 2024-04-01 | Rizvi Syed Ali-aamir | Chief Medical Officer | Buy | 185 k | 0,00 | 0 USD |
| 2024-04-01 | Rizvi Syed Ali-aamir | Chief Medical Officer | Buy | 185 k | 0,00 | 0 USD |
| 2024-03-01 | Gergen Mark J | Executive Chairman | Sell | 34 k | 4,13 | 141 k USD |
| 2024-03-01 | LEONHARDT HARRY J | GC & Chief Compliance Officer | Buy | 81 k | 0,00 | 0 USD |
| 2024-03-01 | LEONHARDT HARRY J | GC & Chief Compliance Officer | Sell | 16 k | 4,13 | 67 k USD |
| 2024-03-01 | Mylet Johanna | Chief Financial Officer | Buy | 81 k | 0,00 | 0 USD |
| 2024-03-01 | Mylet Johanna | Chief Financial Officer | Sell | 18 k | 4,13 | 75 k USD |
| 2024-03-01 | Warner Brent | President, Gene Therapy | Buy | 81 k | 0,00 | 0 USD |
| 2024-03-01 | Warner Brent | President, Gene Therapy | Sell | 36 k | 4,13 | 148 k USD |
| 2024-03-01 | LEONHARDT HARRY J | GC & Chief Compliance Officer | Buy | 81 k | 0,00 | 0 USD |
| 2024-03-01 | LEONHARDT HARRY J | GC & Chief Compliance Officer | Sell | 16 k | 4,13 | 67 k USD |
| 2024-03-01 | Gergen Mark J | Executive Chairman | Sell | 34 k | 4,13 | 141 k USD |
| 2024-03-01 | Mylet Johanna | Chief Financial Officer | Buy | 81 k | 0,00 | 0 USD |
| 2024-03-01 | Mylet Johanna | Chief Financial Officer | Sell | 18 k | 4,13 | 75 k USD |
| 2024-03-01 | Warner Brent | President, Gene Therapy | Buy | 81 k | 0,00 | 0 USD |
| 2024-03-01 | Warner Brent | President, Gene Therapy | Sell | 36 k | 4,13 | 148 k USD |
| 2024-02-01 | Gergen Mark J | Executive Chairman | Sell | 47 k | 3,41 | 161 k USD |
| 2024-02-01 | Gergen Mark J | Executive Chairman | Sell | 47 k | 3,41 | 161 k USD |
| 2024-01-02 | Gergen Mark J | Executive Chairman | Buy | 125 k | 0,00 | 0 USD |
| 2024-01-02 | Gergen Mark J | Executive Chairman | Buy | 125 k | 0,00 | 0 USD |
| 2024-01-02 | Yarema Kristin | President and CEO | Buy | 250 k | 0,00 | 0 USD |
| 2024-01-02 | Yarema Kristin | President and CEO | Buy | 250 k | 0,00 | 0 USD |
| 2023-06-15 | BAUM CHARLES M | Director | Buy | 20 k | 0,00 | 0 USD |
| 2023-06-15 | Collins Cynthia | Director | Buy | 20 k | 0,00 | 0 USD |
| 2023-06-15 | Corning Luke | Director | Buy | 20 k | 0,00 | 0 USD |
| 2023-06-15 | Corning Luke | Director | Buy | 20 k | 0,00 | 0 USD |
| 2023-06-15 | BAUM CHARLES M | Director | Buy | 20 k | 0,00 | 0 USD |
| 2023-06-15 | Lloyd Marcea Bland | Director | Buy | 20 k | 0,00 | 0 USD |
| 2023-06-15 | Schmid John P. | Director | Buy | 20 k | 0,00 | 0 USD |
| 2023-06-15 | Collins Cynthia | Director | Buy | 20 k | 0,00 | 0 USD |
| 2023-06-15 | Schmid John P. | Director | Buy | 20 k | 0,00 | 0 USD |
| 2023-05-01 | Amado Rafael | Director | Buy | 39 k | 0,00 | 0 USD |
| 2023-05-01 | Amado Rafael | Director | Buy | 39 k | 0,00 | 0 USD |
| 2023-04-11 | Yarema Kristin | President, Cell Therapy | Buy | 357 k | 0,00 | 0 USD |
| 2023-04-11 | Yarema Kristin | President, Cell Therapy | Buy | 357 k | 0,00 | 0 USD |
| 2023-03-01 | Gergen Mark J | President and CEO | Buy | 270 k | 0,00 | 0 USD |
| 2023-03-01 | LEONHARDT HARRY J | GC & Chief Compliance Officer | Buy | 93 k | 0,00 | 0 USD |
| 2023-03-01 | LEONHARDT HARRY J | GC & Chief Compliance Officer | Sell | 4 k | 5,35 | 23 k USD |
| 2023-03-01 | Mylet Johanna | Chief Financial Officer | Buy | 93 k | 0,00 | 0 USD |
| 2023-03-01 | Mylet Johanna | Chief Financial Officer | Sell | 4 k | 5,35 | 23 k USD |
| 2023-03-01 | Gergen Mark J | President and CEO | Buy | 270 k | 0,00 | 0 USD |
| 2023-03-01 | LEONHARDT HARRY J | GC & Chief Compliance Officer | Buy | 93 k | 0,00 | 0 USD |
| 2023-03-01 | LEONHARDT HARRY J | GC & Chief Compliance Officer | Sell | 4 k | 5,35 | 23 k USD |
| 2023-03-01 | Mylet Johanna | Chief Financial Officer | Buy | 93 k | 0,00 | 0 USD |
| 2023-03-01 | Mylet Johanna | Chief Financial Officer | Sell | 4 k | 5,35 | 23 k USD |
| 2023-03-01 | Warner Brent | President, Gene Therapy | Buy | 93 k | 0,00 | 0 USD |
| 2023-03-01 | Warner Brent | President, Gene Therapy | Sell | 27 k | 5,35 | 142 k USD |
| 2023-03-01 | Warner Brent | President, Gene Therapy | Buy | 93 k | 0,00 | 0 USD |
| 2023-03-01 | Warner Brent | President, Gene Therapy | Sell | 27 k | 5,35 | 142 k USD |
| 2023-02-01 | Gergen Mark J | President and CEO | Sell | 32 k | 7,00 | 223 k USD |
| 2023-02-01 | Ostertag Eric | Director | Sell | 12 k | 7,00 | 82 k USD |
| 2023-02-01 | Gergen Mark J | President and CEO | Sell | 32 k | 7,00 | 223 k USD |
| 2023-02-01 | Ostertag Eric | Director | Sell | 12 k | 7,00 | 82 k USD |
| 2022-08-08 | Malin Life Sciences Holdings Ltd | 10% owner | Buy | 2.1 mn | 3,50 | 7.5 mn USD |
| 2022-08-08 | Ostertag Eric | Executive Chairman | Buy | 143 k | 3,50 | 500 k USD |
| 2022-08-08 | Malin Life Sciences Holdings Ltd | 10% owner | Buy | 2.1 mn | 3,50 | 7.5 mn USD |
| 2022-08-08 | Ostertag Eric | Executive Chairman | Buy | 143 k | 3,50 | 500 k USD |
| 2022-08-03 | Ostertag Eric | Executive Chairman | Sell | 161 k | 3,69 | 593 k USD |
| 2022-08-03 | Ostertag Eric | Executive Chairman | Sell | 161 k | 3,69 | 593 k USD |
| 2022-06-16 | Collins Cynthia | Director | Buy | 20 k | 0,00 | 0 USD |
| 2022-06-16 | Collins Cynthia | Director | Buy | 20 k | 0,00 | 0 USD |
| 2022-06-16 | BAUM CHARLES M | Director | Buy | 39 k | 0,00 | 0 USD |
| 2022-06-16 | Corning Luke | Director | Buy | 20 k | 0,00 | 0 USD |
| 2022-06-16 | Lloyd Marcea Bland | Director | Buy | 20 k | 0,00 | 0 USD |
| 2022-06-16 | Lloyd Marcea Bland | Director | Buy | 20 k | 0,00 | 0 USD |
| 2022-06-16 | Schmid John P. | Director | Buy | 20 k | 0,00 | 0 USD |
| 2022-06-16 | Corning Luke | Director | Buy | 20 k | 0,00 | 0 USD |
| 2022-06-16 | BAUM CHARLES M | Director | Buy | 39 k | 0,00 | 0 USD |
| 2022-06-16 | Schmid John P. | Director | Buy | 20 k | 0,00 | 0 USD |
| 2022-03-16 | Ingalls Kerry D. | Chief Operating Officer | Buy | 3 k | 3,98 | 12 k USD |
| 2022-03-16 | Ingalls Kerry D. | Chief Operating Officer | Buy | 3 k | 3,98 | 12 k USD |
| 2022-03-01 | Ingalls Kerry D. | Chief Operating Officer | Buy | 50 k | 0,00 | 0 USD |
| 2022-03-01 | LEONHARDT HARRY J | GC & Chief Compliance Officer | Buy | 50 k | 0,00 | 0 USD |
| 2022-03-01 | Mylet Johanna | Chief Financial Officer | Buy | 50 k | 0,00 | 0 USD |
| 2022-03-01 | Warner Brent | President, Gene Therapy | Buy | 308 k | 0,00 | 0 USD |
| 2022-03-01 | Spear Matthew A. | Chief Medical Officer | Buy | 50 k | 0,00 | 0 USD |
| 2022-03-01 | Mylet Johanna | Chief Financial Officer | Buy | 50 k | 0,00 | 0 USD |
| 2022-03-01 | Ingalls Kerry D. | Chief Operating Officer | Buy | 50 k | 0,00 | 0 USD |
| 2022-03-01 | LEONHARDT HARRY J | GC & Chief Compliance Officer | Buy | 50 k | 0,00 | 0 USD |
| 2022-03-01 | Spear Matthew A. | Chief Medical Officer | Buy | 50 k | 0,00 | 0 USD |
| 2022-03-01 | Warner Brent | President, Gene Therapy | Buy | 308 k | 0,00 | 0 USD |
| 2022-02-01 | Gergen Mark J | President and CEO | Buy | 357 k | 0,00 | 0 USD |
| 2022-02-01 | Ostertag Eric | Executive Chairman | Buy | 90 k | 0,00 | 0 USD |
| 2022-02-01 | Ostertag Eric | Executive Chairman | Buy | 90 k | 0,00 | 0 USD |
| 2022-02-01 | Gergen Mark J | President and CEO | Buy | 357 k | 0,00 | 0 USD |
| 2021-12-30 | Ostertag Eric | Executive Chairman | Sell | 94 k | 0,00 | 0 USD |
| 2021-12-30 | Ostertag Eric | Executive Chairman | Sell | 49 k | 0,00 | 0 USD |
| 2021-12-30 | Ostertag Eric | Executive Chairman | Sell | 94 k | 0,00 | 0 USD |
| 2021-12-30 | Ostertag Eric | Executive Chairman | Sell | 49 k | 0,00 | 0 USD |
| 2021-12-21 | Mylet Johanna | Chief Financial Officer | Buy | 3 k | 1,17 | 3 k USD |
| 2021-12-21 | Mylet Johanna | Chief Financial Officer | Buy | 3 k | 1,93 | 6 k USD |
| 2021-12-21 | Mylet Johanna | Chief Financial Officer | Buy | 3 k | 1,17 | 3 k USD |
| 2021-12-21 | Mylet Johanna | Chief Financial Officer | Buy | 3 k | 1,93 | 6 k USD |
| 2021-12-06 | Spear Matthew A. | Chief Medical Officer | Buy | 10 k | 1,32 | 13 k USD |
| 2021-12-06 | Spear Matthew A. | Chief Medical Officer | Buy | 10 k | 1,32 | 13 k USD |
| 2021-12-06 | Malin Life Sciences Holdings Ltd | 10% owner | Buy | 2 k | 6,90 | 13 k USD |
| 2021-12-06 | Malin Life Sciences Holdings Ltd | 10% owner | Buy | 2 k | 6,90 | 13 k USD |
| 2021-12-02 | Malin Life Sciences Holdings Ltd | 10% owner | Buy | 4 k | 6,88 | 30 k USD |
| 2021-12-02 | Malin Life Sciences Holdings Ltd | 10% owner | Buy | 4 k | 6,88 | 30 k USD |
| 2021-12-01 | Malin Life Sciences Holdings Ltd | 10% owner | Buy | 18 k | 6,85 | 126 k USD |
| 2021-12-01 | Malin Life Sciences Holdings Ltd | 10% owner | Buy | 18 k | 6,85 | 126 k USD |
| 2021-11-30 | Malin Life Sciences Holdings Ltd | 10% owner | Buy | 29 k | 6,85 | 196 k USD |
| 2021-11-30 | Malin Life Sciences Holdings Ltd | 10% owner | Buy | 29 k | 6,85 | 196 k USD |
| 2021-11-29 | Malin Life Sciences Holdings Ltd | 10% owner | Buy | 11 k | 6,89 | 76 k USD |
| 2021-11-29 | Malin Life Sciences Holdings Ltd | 10% owner | Buy | 11 k | 6,89 | 76 k USD |
| 2021-11-26 | Malin Life Sciences Holdings Ltd | 10% owner | Buy | 27 k | 6,81 | 185 k USD |
| 2021-11-26 | Malin Life Sciences Holdings Ltd | 10% owner | Buy | 27 k | 6,81 | 185 k USD |
| 2021-11-24 | Malin Life Sciences Holdings Ltd | 10% owner | Buy | 1 k | 6,89 | 7 k USD |
| 2021-11-24 | Malin Life Sciences Holdings Ltd | 10% owner | Buy | 1 k | 6,89 | 7 k USD |
| 2021-11-23 | Malin Life Sciences Holdings Ltd | 10% owner | Buy | 15 k | 6,77 | 99 k USD |
| 2021-11-23 | Malin Life Sciences Holdings Ltd | 10% owner | Buy | 15 k | 6,77 | 99 k USD |
| 2021-11-19 | Malin Life Sciences Holdings Ltd | 10% owner | Buy | 11 k | 7,44 | 83 k USD |
| 2021-11-19 | Malin Life Sciences Holdings Ltd | 10% owner | Buy | 11 k | 7,44 | 83 k USD |
| 2021-11-19 | Ostertag Eric | Chief Executive Officer | Buy | 1 k | 9,15 | 9 k USD |
| 2021-11-19 | Ostertag Eric | Chief Executive Officer | Buy | 1 k | 9,15 | 9 k USD |
| 2021-11-18 | Malin Life Sciences Holdings Ltd | 10% owner | Buy | 71 k | 7,18 | 512 k USD |
| 2021-11-18 | Malin Life Sciences Holdings Ltd | 10% owner | Buy | 71 k | 7,18 | 512 k USD |
| 2021-11-17 | Ingalls Kerry D. | Chief Operating Officer | Buy | 2 k | 7,00 | 14 k USD |
| 2021-11-17 | Malin Life Sciences Holdings Ltd | 10% owner | Buy | 280 k | 7,21 | 2.0 mn USD |
| 2021-11-17 | Malin Life Sciences Holdings Ltd | 10% owner | Buy | 280 k | 7,21 | 2.0 mn USD |
| 2021-11-17 | Ingalls Kerry D. | Chief Operating Officer | Buy | 2 k | 7,00 | 14 k USD |
| 2021-11-16 | Malin Life Sciences Holdings Ltd | 10% owner | Buy | 28 k | 7,17 | 198 k USD |
| 2021-11-16 | Malin Life Sciences Holdings Ltd | 10% owner | Buy | 28 k | 7,17 | 198 k USD |
| 2021-11-08 | Ostertag Eric | Chief Executive Officer | Sell | 10 k | 7,09 | 70 k USD |
| 2021-11-08 | Ostertag Eric | Chief Executive Officer | Sell | 9 k | 7,09 | 64 k USD |
| 2021-11-08 | Ostertag Eric | Chief Executive Officer | Sell | 10 k | 7,09 | 70 k USD |
| 2021-11-08 | Ostertag Eric | Chief Executive Officer | Sell | 9 k | 7,09 | 64 k USD |
| 2021-10-11 | Ostertag Eric | Chief Executive Officer | Buy | 19 k | 9,15 | 170 k USD |
| 2021-10-11 | Ostertag Eric | Chief Executive Officer | Buy | 19 k | 9,15 | 170 k USD |
| 2021-10-01 | Ostertag Eric | Chief Executive Officer | Sell | 10 k | 7,02 | 73 k USD |
| 2021-10-01 | Ostertag Eric | Chief Executive Officer | Sell | 10 k | 7,02 | 67 k USD |
| 2021-10-01 | Ostertag Eric | Chief Executive Officer | Sell | 10 k | 7,02 | 73 k USD |
| 2021-10-01 | Ostertag Eric | Chief Executive Officer | Sell | 10 k | 7,02 | 67 k USD |
| 2021-09-20 | Ostertag Eric | Chief Executive Officer | Sell | 20 k | 8,00 | 160 k USD |
| 2021-09-20 | Ostertag Eric | Chief Executive Officer | Sell | 20 k | 8,00 | 160 k USD |
| 2021-09-14 | Ostertag Eric | Chief Executive Officer | Sell | 20 k | 8,14 | 163 k USD |
| 2021-09-14 | Ostertag Eric | Chief Executive Officer | Sell | 20 k | 8,14 | 163 k USD |
| 2021-09-13 | Ostertag Eric | Chief Executive Officer | Buy | 3 k | 1,17 | 3 k USD |
| 2021-09-13 | Ostertag Eric | Chief Executive Officer | Buy | 19 k | 9,15 | 169 k USD |
| 2021-09-13 | Ostertag Eric | Chief Executive Officer | Buy | 3 k | 1,17 | 3 k USD |
| 2021-09-13 | Ostertag Eric | Chief Executive Officer | Buy | 19 k | 9,15 | 169 k USD |
| 2021-09-09 | Spear Matthew A. | Chief Medical Officer | Buy | 10 k | 1,32 | 13 k USD |
| 2021-09-09 | Spear Matthew A. | Chief Medical Officer | Buy | 10 k | 1,32 | 13 k USD |
| 2021-09-02 | Ostertag Eric | Chief Executive Officer | Sell | 32 k | 8,34 | 267 k USD |
| 2021-09-02 | Ostertag Eric | Chief Executive Officer | Sell | 29 k | 8,34 | 244 k USD |
| 2021-09-02 | Ostertag Eric | Chief Executive Officer | Sell | 32 k | 8,34 | 267 k USD |
| 2021-09-02 | Ostertag Eric | Chief Executive Officer | Sell | 29 k | 8,34 | 244 k USD |
| 2021-09-01 | Ostertag Eric | Chief Executive Officer | Sell | 27 k | 8,46 | 226 k USD |
| 2021-09-01 | Ostertag Eric | Chief Executive Officer | Sell | 24 k | 8,46 | 207 k USD |
| 2021-09-01 | Ostertag Eric | Chief Executive Officer | Sell | 27 k | 8,46 | 226 k USD |
| 2021-09-01 | Ostertag Eric | Chief Executive Officer | Sell | 24 k | 8,46 | 207 k USD |
| 2021-08-20 | Spear Matthew A. | Chief Medical Officer | Buy | 4 k | 1,32 | 5 k USD |
| 2021-08-20 | Spear Matthew A. | Chief Medical Officer | Sell | 4 k | 8,79 | 35 k USD |
| 2021-08-20 | Spear Matthew A. | Chief Medical Officer | Buy | 4 k | 1,32 | 5 k USD |
| 2021-08-20 | Spear Matthew A. | Chief Medical Officer | Sell | 4 k | 8,79 | 35 k USD |
| 2021-08-06 | Ostertag Eric | Chief Executive Officer | Buy | 111 k | 9,15 | 1.0 mn USD |
| 2021-08-06 | Ostertag Eric | Chief Executive Officer | Buy | 111 k | 9,15 | 1.0 mn USD |
| 2021-08-03 | Ostertag Eric | Chief Executive Officer | Sell | 10 k | 7,99 | 83 k USD |
| 2021-08-03 | Ostertag Eric | Chief Executive Officer | Sell | 10 k | 7,99 | 76 k USD |
| 2021-08-03 | Ostertag Eric | Chief Executive Officer | Sell | 10 k | 7,99 | 83 k USD |
| 2021-08-03 | Ostertag Eric | Chief Executive Officer | Sell | 10 k | 7,99 | 76 k USD |
| 2021-08-02 | Ostertag Eric | Chief Executive Officer | Sell | 7 k | 8,13 | 58 k USD |
| 2021-08-02 | Ostertag Eric | Chief Executive Officer | Sell | 7 k | 8,13 | 53 k USD |
| 2021-08-02 | Ostertag Eric | Chief Executive Officer | Sell | 7 k | 8,13 | 58 k USD |
| 2021-08-02 | Ostertag Eric | Chief Executive Officer | Sell | 7 k | 8,13 | 53 k USD |
| 2021-07-28 | Spear Matthew A. | Chief Medical Officer | Buy | 20 k | 1,32 | 26 k USD |
| 2021-07-28 | Spear Matthew A. | Chief Medical Officer | Buy | 20 k | 1,32 | 26 k USD |
| 2021-07-02 | Ostertag Eric | Chief Executive Officer | Sell | 104 | 9,65 | 1 k USD |
| 2021-07-02 | Ostertag Eric | Chief Executive Officer | Sell | 14 k | 8,90 | 127 k USD |
| 2021-07-02 | Ostertag Eric | Chief Executive Officer | Sell | 96 | 9,65 | 926 USD |
| 2021-07-02 | Ostertag Eric | Chief Executive Officer | Sell | 13 k | 8,90 | 116 k USD |
| 2021-07-02 | Ostertag Eric | Chief Executive Officer | Sell | 104 | 9,65 | 1 k USD |
| 2021-07-02 | Ostertag Eric | Chief Executive Officer | Sell | 14 k | 8,90 | 127 k USD |
| 2021-07-02 | Ostertag Eric | Chief Executive Officer | Sell | 96 | 9,65 | 926 USD |
| 2021-07-02 | Ostertag Eric | Chief Executive Officer | Sell | 13 k | 8,90 | 116 k USD |
| 2021-07-01 | Ostertag Eric | Chief Executive Officer | Sell | 11 k | 9,77 | 105 k USD |
| 2021-07-01 | Ostertag Eric | Chief Executive Officer | Sell | 10 k | 9,77 | 96 k USD |
| 2021-07-01 | Ostertag Eric | Chief Executive Officer | Sell | 11 k | 9,77 | 105 k USD |
| 2021-07-01 | Ostertag Eric | Chief Executive Officer | Sell | 10 k | 9,77 | 96 k USD |
| 2021-06-17 | Spear Matthew A. | Chief Medical Officer | Buy | 5 k | 1,32 | 7 k USD |
| 2021-06-17 | Spear Matthew A. | Chief Medical Officer | Buy | 5 k | 1,32 | 7 k USD |
| 2021-06-11 | Spear Matthew A. | Chief Medical Officer | Buy | 4 k | 1,32 | 5 k USD |
| 2021-06-11 | Spear Matthew A. | Chief Medical Officer | Sell | 4 k | 9,44 | 38 k USD |
| 2021-06-11 | Spear Matthew A. | Chief Medical Officer | Buy | 4 k | 1,32 | 5 k USD |
| 2021-06-11 | Spear Matthew A. | Chief Medical Officer | Sell | 4 k | 9,44 | 38 k USD |
| 2021-06-02 | Ostertag Eric | Chief Executive Officer | Sell | 21 k | 8,34 | 177 k USD |
| 2021-06-02 | Ostertag Eric | Chief Executive Officer | Sell | 19 k | 8,34 | 162 k USD |
| 2021-06-02 | Ostertag Eric | Chief Executive Officer | Sell | 21 k | 8,34 | 177 k USD |
| 2021-06-02 | Ostertag Eric | Chief Executive Officer | Sell | 19 k | 8,34 | 162 k USD |
| 2021-06-01 | Ostertag Eric | Chief Executive Officer | Sell | 21 k | 8,61 | 185 k USD |
| 2021-06-01 | Ostertag Eric | Chief Executive Officer | Sell | 20 k | 8,61 | 170 k USD |
| 2021-06-01 | Ostertag Eric | Chief Executive Officer | Sell | 21 k | 8,61 | 185 k USD |
| 2021-06-01 | Ostertag Eric | Chief Executive Officer | Sell | 20 k | 8,61 | 170 k USD |
| 2021-05-04 | Ostertag Eric | Chief Executive Officer | Sell | 19 k | 8,44 | 158 k USD |
| 2021-05-04 | Ostertag Eric | Chief Executive Officer | Sell | 17 k | 8,44 | 145 k USD |
| 2021-05-04 | Ostertag Eric | Chief Executive Officer | Sell | 19 k | 8,44 | 158 k USD |
| 2021-05-04 | Ostertag Eric | Chief Executive Officer | Sell | 17 k | 8,44 | 145 k USD |
| 2021-05-03 | Ostertag Eric | Chief Executive Officer | Sell | 10 k | 9,01 | 86 k USD |
| 2021-05-03 | Ostertag Eric | Chief Executive Officer | Sell | 9 k | 9,01 | 79 k USD |
| 2021-05-03 | Ostertag Eric | Chief Executive Officer | Sell | 10 k | 9,01 | 86 k USD |
| 2021-05-03 | Ostertag Eric | Chief Executive Officer | Sell | 9 k | 9,01 | 79 k USD |
| 2021-04-23 | Spear Matthew A. | Chief Medical Officer | Buy | 5 k | 1,32 | 7 k USD |
| 2021-04-23 | Spear Matthew A. | Chief Medical Officer | Buy | 5 k | 1,32 | 7 k USD |
| 2021-04-21 | Spear Matthew A. | Chief Medical Officer | Buy | 4 k | 1,32 | 5 k USD |
| 2021-04-21 | Spear Matthew A. | Chief Medical Officer | Sell | 4 k | 8,44 | 34 k USD |
| 2021-04-21 | Spear Matthew A. | Chief Medical Officer | Buy | 4 k | 1,32 | 5 k USD |
| 2021-04-21 | Spear Matthew A. | Chief Medical Officer | Sell | 4 k | 8,44 | 34 k USD |
| 2021-04-05 | Ostertag Eric | Chief Executive Officer | Sell | 29 k | 9,63 | 275 k USD |
| 2021-04-05 | Ostertag Eric | Chief Executive Officer | Sell | 2 k | 10,32 | 17 k USD |
| 2021-04-05 | Ostertag Eric | Chief Executive Officer | Sell | 26 k | 9,63 | 252 k USD |
| 2021-04-05 | Ostertag Eric | Chief Executive Officer | Sell | 1 k | 10,32 | 15 k USD |
| 2021-04-05 | Ostertag Eric | Chief Executive Officer | Sell | 29 k | 9,63 | 275 k USD |
| 2021-04-05 | Ostertag Eric | Chief Executive Officer | Sell | 2 k | 10,32 | 17 k USD |
| 2021-04-05 | Ostertag Eric | Chief Executive Officer | Sell | 26 k | 9,63 | 252 k USD |
| 2021-04-05 | Ostertag Eric | Chief Executive Officer | Sell | 1 k | 10,32 | 15 k USD |
| 2021-04-01 | Ostertag Eric | Chief Executive Officer | Sell | 30 k | 9,55 | 285 k USD |
| 2021-04-01 | Ostertag Eric | Chief Executive Officer | Sell | 27 k | 9,55 | 261 k USD |
| 2021-04-01 | Ostertag Eric | Chief Executive Officer | Sell | 30 k | 9,55 | 285 k USD |
| 2021-04-01 | Ostertag Eric | Chief Executive Officer | Sell | 27 k | 9,55 | 261 k USD |
| 2021-03-02 | Ostertag Eric | Chief Executive Officer | Sell | 30 k | 11,54 | 344 k USD |
| 2021-03-02 | Ostertag Eric | Chief Executive Officer | Sell | 27 k | 11,54 | 315 k USD |
| 2021-03-02 | Ostertag Eric | Chief Executive Officer | Sell | 30 k | 11,54 | 344 k USD |
| 2021-03-02 | Ostertag Eric | Chief Executive Officer | Sell | 27 k | 11,54 | 315 k USD |
| 2021-03-01 | Ostertag Eric | Chief Executive Officer | Sell | 30 k | 11,66 | 346 k USD |
| 2021-03-01 | Ostertag Eric | Chief Executive Officer | Sell | 528 | 12,12 | 6 k USD |
| 2021-03-01 | Ostertag Eric | Chief Executive Officer | Sell | 27 k | 11,66 | 317 k USD |
| 2021-03-01 | Ostertag Eric | Chief Executive Officer | Sell | 484 | 12,12 | 6 k USD |
| 2021-03-01 | Ostertag Eric | Chief Executive Officer | Sell | 30 k | 11,66 | 346 k USD |
| 2021-03-01 | Ostertag Eric | Chief Executive Officer | Sell | 528 | 12,12 | 6 k USD |
| 2021-03-01 | Ostertag Eric | Chief Executive Officer | Sell | 27 k | 11,66 | 317 k USD |
| 2021-03-01 | Ostertag Eric | Chief Executive Officer | Sell | 484 | 12,12 | 6 k USD |
| 2021-02-23 | Ostertag Eric | Chief Executive Officer | Buy | 111 k | 1,17 | 131 k USD |
| 2021-02-23 | Ostertag Eric | Chief Executive Officer | Buy | 111 k | 1,17 | 131 k USD |
| 2021-02-16 | Ostertag Eric | Chief Executive Officer | Sell | 133 k | 10,00 | 1.3 mn USD |
| 2021-02-16 | Ostertag Eric | Chief Executive Officer | Sell | 133 k | 10,00 | 1.3 mn USD |
| 2021-02-10 | Ostertag Eric | Chief Executive Officer | Buy | 68 k | 1,29 | 87 k USD |
| 2021-02-10 | Ostertag Eric | Chief Executive Officer | Sell | 12 k | 10,00 | 124 k USD |
| 2021-02-10 | Ostertag Eric | Chief Executive Officer | Buy | 68 k | 1,29 | 87 k USD |
| 2021-02-10 | Ostertag Eric | Chief Executive Officer | Sell | 12 k | 10,00 | 124 k USD |
| 2021-01-21 | Ostertag Eric | Chief Executive Officer | Sell | 4 k | 10,00 | 45 k USD |
| 2021-01-21 | Ostertag Eric | Chief Executive Officer | Sell | 4 k | 10,00 | 45 k USD |
| 2021-01-15 | Mylet Johanna | Senior Vice President, Finance | Buy | 5 k | 0,30 | 1 k USD |
| 2021-01-15 | Spear Matthew A. | Chief Medical Officer | Buy | 8 k | 1,32 | 10 k USD |
| 2021-01-15 | Mylet Johanna | Senior Vice President, Finance | Buy | 5 k | 0,30 | 1 k USD |
| 2021-01-15 | Spear Matthew A. | Chief Medical Officer | Buy | 8 k | 1,32 | 10 k USD |
| 2021-01-08 | Spear Matthew A. | Chief Medical Officer | Buy | 4 k | 1,32 | 5 k USD |
| 2021-01-08 | Spear Matthew A. | Chief Medical Officer | Buy | 4 k | 1,32 | 5 k USD |
| 2020-07-14 | NOVARTIS PHARMA AG | 10% owner | Buy | 5.9 mn | – | – |
| 2020-07-14 | NOVARTIS PHARMA AG | 10% owner | Buy | 5.9 mn | – | – |
| 2020-07-14 | NOVARTIS PHARMA AG | 10% owner | Buy | 5.9 mn | – | – |
| 2020-07-14 | Hirsch David | Director | Buy | 2.5 mn | – | – |
| 2020-07-14 | Hirsch David | Director | Buy | 250 k | 16,00 | 4.0 mn USD |
| 2020-07-14 | Lloyd Marcea Bland | Director | Buy | 10 k | 16,00 | 160 k USD |
| 2020-07-14 | Malin Life Sciences Holdings Ltd | 10% owner | Buy | 7.0 mn | – | – |
| 2020-07-14 | Malin Life Sciences Holdings Ltd | 10% owner | Buy | 1.2 mn | – | – |
| 2020-07-14 | Malin Life Sciences Holdings Ltd | 10% owner | Buy | 690 k | – | – |
| 2020-07-14 | Malin Life Sciences Holdings Ltd | 10% owner | Buy | 315 k | – | – |
| 2020-07-14 | Malin Life Sciences Holdings Ltd | 10% owner | Buy | 7.0 mn | – | – |
| 2020-07-14 | Malin Life Sciences Holdings Ltd | 10% owner | Buy | 1.2 mn | – | – |
| 2020-07-14 | Malin Life Sciences Holdings Ltd | 10% owner | Buy | 690 k | – | – |
| 2020-07-14 | Malin Life Sciences Holdings Ltd | 10% owner | Buy | 315 k | – | – |
| 2020-07-14 | Murphy Sean | Director, 10% owner | Buy | 7.0 mn | – | – |
| 2020-07-14 | Murphy Sean | Director, 10% owner | Buy | 1.2 mn | – | – |
| 2020-07-14 | Murphy Sean | Director, 10% owner | Buy | 690 k | – | – |
| 2020-07-14 | Murphy Sean | Director, 10% owner | Buy | 315 k | – | – |
| 2020-07-14 | Murphy Sean | Director, 10% owner | Buy | 10 k | 16,00 | 160 k USD |
| 2020-07-14 | Ostertag Eric | Chief Executive Officer | Buy | 256 k | – | – |
| 2020-07-14 | Ostertag Eric | Chief Executive Officer | Buy | 351 k | – | – |
| 2020-07-14 | Malin Life Sciences Holdings Ltd | 10% owner | Buy | 7.0 mn | – | – |
| 2020-07-14 | Malin Life Sciences Holdings Ltd | 10% owner | Buy | 1.2 mn | – | – |
| 2020-07-14 | Malin Life Sciences Holdings Ltd | 10% owner | Buy | 690 k | – | – |
| 2020-07-14 | Malin Life Sciences Holdings Ltd | 10% owner | Buy | 315 k | – | – |
| 2020-07-14 | Lloyd Marcea Bland | Director | Buy | 10 k | 16,00 | 160 k USD |
| 2020-07-14 | Hirsch David | Director | Buy | 2.5 mn | – | – |
| 2020-07-14 | Hirsch David | Director | Buy | 250 k | 16,00 | 4.0 mn USD |
| 2020-07-14 | Murphy Sean | Director, 10% owner | Buy | 7.0 mn | – | – |
| 2020-07-14 | Murphy Sean | Director, 10% owner | Buy | 1.2 mn | – | – |
| 2020-07-14 | Murphy Sean | Director, 10% owner | Buy | 690 k | – | – |
| 2020-07-14 | Murphy Sean | Director, 10% owner | Buy | 315 k | – | – |
| 2020-07-14 | Murphy Sean | Director, 10% owner | Buy | 10 k | 16,00 | 160 k USD |
| 2020-07-14 | Ostertag Eric | Chief Executive Officer | Buy | 256 k | – | – |
| 2020-07-14 | Ostertag Eric | Chief Executive Officer | Buy | 351 k | – | – |